Mobile App

Google Play Apple Store
Conversations in Hematology/Oncology: Incorporating Key Updates in the Treatment of Follicular Lymphoma: A Discussion Following ASH 2023 on Assimilating Practice-Changing Breakthroughs
AMA/ABS/ANCC/ACPE Activity
Conversations in Hematology/Oncology: Incorporating Key Updates in the Treatment of Follicular Lymphoma: A Discussion Following ASH 2023 on Assimilating Practice-Changing Breakthroughs is a discussion between key opinion leaders to identify and integrate crucial advances in follicular lymphoma presented at the 2023 American Society of Hematology (ASH) annual conference.
Review the activity and claim AMA/ABS/ANCC/ACPE credit/contact hour after completion of a brief pretest and posttest/evaluation.




Gilles Salles, MD Gilles Salles, MD
Chief, Lymphoma Service
Memorial Sloan Kettering Cancer Center

Matthew Lunning, DO Matthew Lunning, DO
Associate Professor of Hematology/Oncology
University of Nebraska Medical Center

20
Supported by an independent educational grant from
Genentech, a member of the Roche Group

Launch Date: January 26, 2024
Release Date: January 26, 2024
Expiration Date: December 31, 2024

TBD
Mini Module
7684
Conversations_FollicularLymphoma_clientSelection_1730x162.png
Hematology-Oncology

CookieConsent

Change Settings